Skip to content

Upstream Bio, Inc. UPB Q2 2025 earnings

Reported August 6, 2025 · Before market open

Revenue estimate$317.0K
EPS estimate-$0.61

Next report

Aug 5, 2026 (In 3 weeks)
Revenue estimate$431.1K
EPS estimate-$0.78

Financials

Q2 2025

Income statement

See full
Revenue$937.0K+83.7%
Operating income-$44.3M-153%
Net income-$40.0M-172%
EPS (diluted)-$0.74+88.6%

Balance sheet

See full
Cash & equivalents$45.5M-4.0%
Total debt$1.6M
Total equity$408.7M+379%
Total assets$420.5M

Cash flow

See full
Operating cash flow-$39.2M-388%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$612.71M
Enterprise value$568.81M
P/S225×

Profitability

See full
Operating margin-4,464.6%+14,312pp
Net margin-3,836.6%-40,870pp

Returns & leverage

See full
Debt / equity
Current ratio38.3×

Versus estimates

Ask the moment Upstream Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Upstream Bio, Inc. report Q2 2025 earnings?
Upstream Bio, Inc. (UPB) reported Q2 2025 earnings on August 6, 2025 before market open.
What were Upstream Bio, Inc.'s Q2 2025 revenue and EPS?
Upstream Bio, Inc. reported revenue of $937.0K and diluted EPS of $-0.74 for Q2 2025.
Did Upstream Bio, Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $317.0K by $620.0K. EPS missed the consensus estimate of $-0.61 by $0.13.
Where can I find Upstream Bio, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-103534) directly on SEC EDGAR. The filing index links above go to sec.gov.